Tower Research Capital »

Summit Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $246k 12k 20.66
2025-06-30 $341k 16k 21.28
2025-03-31 $179k 9.3k 19.29
2024-12-31 $302k 17k 17.85
2024-09-30 $33k 1.5k 21.90
2024-06-30 $537k 69k 7.80
2024-03-31 $46k 11k 4.14
2023-09-30 $13k 6.8k 1.87
2023-06-30 $12k 4.9k 2.51
2023-03-31 $36k 21k 1.72
2022-12-31 $115k 27k 4.24
2022-09-30 $14k 11k 1.23
2022-06-30 $9.0k 9.4k 0.96
2022-03-31 $10k 4.2k 2.39
2021-12-31 $11k 4.1k 2.70
2021-09-30 $12k 2.4k 5.09
2021-06-30 $26k 3.4k 7.57
2021-03-31 $28k 4.8k 5.81
2020-12-31 $18k 3.8k 4.76